Ujjawal H. Gandhi

Hematology

150 Parkway Office Ct Ste 200
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.

Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cells.

Journal: Cell reports

Published: July 22, 2022

Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.

Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.

Journal: American journal of hematology

Published: July 15, 2020

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.

Journal: Leukemia

Published: December 23, 2018

Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma.

Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 10, 2017

Selenium suppresses leukemia through the action of endogenous eicosanoids.

Selenium suppresses leukemia through the action of endogenous eicosanoids.

Journal: Cancer research

Published: May 30, 2014

Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.

Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice.

Journal: Blood

Published: October 05, 2011

Showing 1-6 of 6

Last Updated: 09/26/2026